| Literature DB >> 12234922 |
Brian M Iritani1, Jeffrey Delrow, Carla Grandori, Ivan Gomez, Meredith Klacking, Leni Sue Carlos, Robert N Eisenman.
Abstract
Activated lymphocytes must increase in size and duplicate their contents (cell growth) before they can divide. The molecular events that control cell growth in proliferating lymphocytes and other metazoan cells are still unclear. Here, we utilized transgenesis to provide evidence suggesting that the basic helix-loop- helix-zipper (bHLHZ) transcriptional repressor Mad1, considered to be an antagonist of Myc function, inhibits lymphocyte expansion, maturation and growth following pre-T-cell receptor (pre-TCR) and TCR stimulation. Furthermore, we utilized cDNA microarray technology to determine that, of the genes repressed by Mad1, the majority (77%) are involved in cell growth, which correlates with a decrease in size of Mad1 transgenic thymocytes. Over 80% of the genes repressed by Mad1 have previously been found to be induced by Myc. These results suggest that a balance between Myc and Mad levels may normally modulate lymphocyte proliferation and development in part by controlling expression of growth-regulating genes.Entities:
Mesh:
Substances:
Year: 2002 PMID: 12234922 PMCID: PMC126288 DOI: 10.1093/emboj/cdf492
Source DB: PubMed Journal: EMBO J ISSN: 0261-4189 Impact factor: 11.598